Headline up to 65 characters • Employment: Institution/practice name • Courses & Meetings: Course name Teaser: up to 225 characters • Employment: Position title, and location • Courses & Meetings: Course sponsor name, dates, and location Body Copy: up to 500 words Logo and Primary Image: High resolution JPEG/ PNG
Headline priorities Improving play, cultural, arts, learning and leisure opportunities for the people of Kent NI11 Engagement in the arts Increasing involvement in active lifestyles, participation in sport for all ages and maximising the legacy of the 2012 Olympic and Paralympic games NI8 Adult participation in sport and active recreation Improving the participation and engagement of all children and young people in community activities NI110 Young people’s participation in positive activities Keeping Kent Moving Kent is a gateway to Europe and is of great local, regional, national and international importance with its strategic infrastructure including the ports and Channel Tunnel. Congestion on Kent’s road network is increasing because people are making more of their journeys by car, are making longer journeys and an increasing volume of goods is being transported on our roads. Therefore, reducing this need to travel will be achieved by locating services and jobs nearer to where people live, by encouraging people to make journeys by more efficient modes of travel like the bus, walking and cycling and by making a journey unnecessary through home working and other initiatives. Xxxx is committed to continuing the excellent progress in making travel safer across the county, particularly for the 17-25 age group where fatalities are most prevalent. Headline priorities Reducing the need to travel and making better use of existing transport infrastructure and reducing the impact of international traffic on Kent and its communities NI198 Children travelling to school – mode of travel usually used Improving accessibility to jobs and essential services by sustainable modes of travel NI175 Access to services and facilities by public transport, walking and cycling Saving lives and reducing injuries of the roads and pavements NI47 People killed or seriously injured in road traffic accidents
Headline. National Treasury Directorate Identification: 899999090-2 No. Account: 00000000 Account Type: Current Bank: Citibank N.Y. Intermediary Bank: Not required SWIFT: XXXXXX00 ABA: 000000000 Annex 2.6(b) Buyer's Bank Account Headline: ECOPETROL SA Identification: 899,999,068-1 No. Account: 00000000 Account Type: IBDDA Bank: Citibank N.A. Intermediary Bank: N/A. SWIFT: XXXXXX00 ABA: 000000000 Address: 000 Xxxx Xxxxxx, Xxx XxxxXX 00000, Xxxxxx Xxxxxx 42 Annex 2.7(c) Buyer's Certificate Bogota, [●] of [●] of 2021 Gentlemen Ministry of Finance and Public Credit Attention: Bogota, Colombia REFERENCE:Inter-Administrative Agreement for the Sale of Actions Buyer's Closing Certification Dear Sirs, This certificate is signed and delivered in compliance with Section 2.7(c) of the Interadministrative Agreement for the Sale of Shares dated [●], [●], 2021 (the "Agreement"), signed between Ecopetrol S.A. (the "Buyer"), and the Nation Ministry of Finance and Public Credit (The "Seller"). Capitalized terms not expressly defined herein shall have the same meaning as those terms in the Agreement. Buyer certifies that on the Closing Date: Buyer's Corporate Authorizations remain in effect and are fully binding; and The conditions set forth in Section 6.3 of the Agreement have been met. Kind regards, Signature: Name: Position: Legal Representative Ecopetrol S.A. Annex 2.8(d) Electronic document Deceval Annex 2.8(e) Seller's Certificate Bogota, [·] of [·] of 2021
Headline. Duntiam qui doluptas et et pedisin pos restiis cienti cullore, simporese maio. Ipid quatque nossimincto mos ut aceritibus qui omnimperis consequ atiaspe ratur, ommodis apici num et endisit di quideleni nes sus est optatur istiscimi, volorrume. Cuptae et eos aperro beaqui net autaspe. Im in non consed mo berciissum aspiend eliqui berchitae num im laborror sum as molupta tempore la vent, nos moloreprate que landipidel iduciis nullaborum volore verum nullest, volo tet, si con xxx xxxx volecate es santi te dolut estia cusam quunt. Ehenis adis ma plaborescit pore di nihicto tem cum quis accust provit rem harum cusam faciates erspediam que ea doluptio. Eperem dolo bla qui demoles truptat. Porro magnim sum ad qui cuptatem eatur? Equidem fuga. Occus volo magnis evel molorro et optatur? Fuga. Itat occati omnitem xxxx nem sim lab ipsum est a aut expeles sitatendam, iur solute cone essequatem aboruptiate velliam volor as eos iuntore pelloriberum nis iusa sit earum volorundi utam quatus assi aliquunt ut a entem fugia xxxx xxxxxx natibeaqui blam voluptae comnis none ipsamet atus. Ignatibusda xxxx xxxx ut quidest estiore xxxxx et eatio temque od quaspie nimilla ccatiae libus, que dionseq uodites sediorro es serumquo cum quid ut aut omnienihici omnihil ipiti audi ommo odipsam qui oditasp icatios idestru mquasi am, se seribusant intis sed mincipsus, que sit volest, optur, sim qui quas essecat. SUBMIT
Headline. The headlines used in this Agreement are for the convenience of reading, shall not be construed as the interpretation of the clauses hereof, and shall not affect the meaning of any clause hereof by whatsoever ways.
Headline. Xxxxxxx, a GSK company, enters into an agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis Body: Xxxxxxx, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Xxxxxxx of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong. WBI-1001 is currently in Phase II clinical development for the treatment of psoriasis and atopic dermatitis. The transaction is subject to approval by the shareholders or Welichem. Welichem will receive an initial payment of Canadian $35 million and is eligible to receive total milestone payments of Canadian $180 million upon achievement of certain development and commercial milestones. Under terms of the agreement, Xxxxxxx has also received a conditional right to acquire further exclusive rights to develop and commercialize WBI-1001 in China, Taiwan, Macao and Hong Kong, collectively, at a future date upon satisfaction of certain conditions and upon making an additional payment of Canadian $15 million. “I’m quite pleased to build upon Xxxxxxx’x clinical pipeline of novel dermatology assets with the acquisition of WBI-1001” said Xxxxxxx Xxxxx, Senior Vice President and Head of Research and Development, Xxxxxxx “We have a strong commitment to patients with skin conditions and are excited to undertake development of this innovative agent.” About WBI-1001: WBI-1001 is a novel, non-steroidal, topical anti-inflammatory new chemical entity (NCE) agent that has demonstrated efficacy and safety in Ph1 and Ph2 clinical trials for the treatment of mild to moderate psoriasis and moderate to severe atopic dermatitis (AD) for up to 12 weeks as a single therapy. About Xxxxxxx, a GSK company Xxxxxxx, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin. Xxxxxxx’x dedication to innovation, along with its focus on pharmaceutical, over-the-counter and aesthetic dermatology products, has established Xxxxxxx as a world leader in the skin health industry. To learn more about Xxxxxxx, visit xxx.xxxxxxx.xxx. GlaxoSmithKline Enquiries: [***] [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. EXECUTION CO...
Headline. 3. Full story
Headline. YEAR: Indicate the year in which the program will be carried out; Contract Area: Indicate the area in which the program will be carried out; BASIN/STATE: Indicate the Sedimentary Basin and the State in which the area is located; OPERATOR: Indicate the name of the Operator Contract Area; N0. OF THE CONTRACT: Indicate the contract number; DATE OF ISSUANCE: Indicate the date on which the document will be delivered to the National Petroleum Agency (ANP).
Headline. Massage Envy Settlement Text: If you purchased a massage session from a Massage Envy® Spa in MO, you may be entitled to benefits from a Class Action Settlement. Website: xxx.XxxxxxxxXxxxxxxXxxxxxxx.xxx Social Media Ad – Right Hand Side (Facebook) Headline: Massage Envy Settlement Text: Massage Envy® Spa customers in MO may benefit from a Class Action Settlement Website: xxx.XxxxxxxxXxxxxxxXxxxxxxx.xxx Exhibit 0 XXXXXX XXXXXX XXXXXXXX XXXXX XXXXXXX XXXXXXXX XX XXXXXXXX EASTERN DIVISION XXXX XXXXXXX and XXXXX XXXXX, individually and on behalf of others similarly situated, Plaintiffs, v. MASSAGE ENVY FRANCHISING, LLC, a Delaware corporation, Defendant. Case No. 4:10-cv-00807-CDP ORDER ON CLASS REPRESENTATIVES’ MOTION FOR PRELIMINARY APPROVAL Class Representatives’ Motion for Preliminary Approval of a Class Action Settlement (the “Motion”) was submitted on November 25, 2019 (the “Motion”). In connection with the Motion, the Court considered the proposed Class Action Settlement Agreement and Release (attached as Exhibit A to the Motion) (the “AGREEMENT”), the Plaintiffs’ Response to Order of March 5, 2020 (Doc. #41), the Amended Class Action Settlement Agreement and Release (Doc. # ) (“AMENDED AGREEMENT”), the submissions of counsel, and all other papers filed in this action. This Order incorporates by reference the definitions in the AMENDED AGREEMENT and capitalized terms shall have the meaning ascribed to them in the AMENDED AGREEMENT. The matter having been submitted, and good cause appearing, IT IS HEREBY ORDERED, ADJUDGED, AND DECREED THAT:
Headline. ASUS Rog Strix Laptop Settlement Website: xxx.xxxxxxxxxxxxxxxxxxxx.xxx Description: Court Authorized Notice IF YOU PURCHASED AN ASUS ROG STRIX GL 502 VS OR GL 502 VSK LAPTOP AFTER MAY 4 , 2014 , A CLASS ACTION SETTLEMENT MAY AFFECT YOUR RIGHTS.
